Drug Trial Radar · NCT05813496
Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt
Last checked: Nov 19, 2026Latest source record: Mar 25, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
430
Actual
Start
Oct 26, 2022
Primary completion
Aug 3, 2024
Study completion Dec 11, 2024
Sponsor
- Lead sponsor
- Eva PharmaIndustry
- Sponsor type
- Industry
- Collaborators
- MARC-CRO
- First posted
- Apr 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to find out whether ALA is effective and safe for treating Egyptian diabetic patients with symptomatic polyneuropathy. The ADA stated that despite the exploration of several pharmacological therapies for DPN management, substantial evidence on medicines that modify the natural history of DPN is still absent. This is a multicenter, interventional, two-arm, parallel-group, randomized, double-blinded, placebo-controlled, phase IV trial. Patients will be administered either one tablet of placebo or one tablet containing 600 mg of ALA twice a day for 24 weeks, depending on the randomization process.
Conditions
- Polyneuropathy, Diabetic
Interventions
Alpha-Lipoic Acid (ALA)Drug
Oral tablet
PlaceboDrug
Microcrystalline cellulose (Ph 101) 427.5 mg, Magnesium stearate 71.25 mg, Sodium laurayl sulphate 6 mg, Croscarmellose sodium 11.25 mg, Silica, colloid anhydrous 11.25 mg, and Purified talc 30 mg.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To compare the relative change in NCS parameters between the study armsTime frame: After four weeks of treatment
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Mansoura University Hospital
Al Mansurah, Egypt
Alexandria University
Alexandria, Bab Sharqi, Egypt
Beni Suef University Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt
Ain-Shams University Hospital
Cairo, Heliopolis, Egypt
Menoufia University Hospital
Shibīn al Kawm, Shebin El Kom, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.